Consent given pursuant to sections 14 and 14A for the importation and supply of the therapeutic goods specified - between 15 December 2014 and 16 December 2017

Administered by Department of Health, Disability and Ageing

Legislation au C2014G02120 In force Gazette

Legislation content

COMMONWEALTH OF AUSTRALIA

Department of Health
Therapeutic Goods Administration

THERAPEUTIC GOODS ACT 1989

Section 14 and 14A Notice

 

 

On 15 December 2014, the delegate of the Secretary of the Department of Health for the purposes of subsection 14 and 14A of the Therapeutic Goods Act 1989 (“the Act”), on the application of Bayer Australia Ltd, gave consent to the importation  and supply of:

  • the products shown in the attachment that do not conform with the requirements of the paragraph 3(2)(l) of the Therapeutic Goods Order No. 69 – General requirements for labels for medicines (TGO 69), in that their labels display the name and address of the previous sponsor (Merck Sharp & Dohme (Australia) Pty Ltd) instead of displaying the name and address of the current sponsor or supplier.

The consent is effective from 15 December 2014 until 16 December 2017. 

The delegate of the Secretary, under subsection 15(1) of the Act, made the consent subject to the following condition:

  1. The labels to which this consent applies are those previously approved for the former sponsor Merck Sharp & Dohme (Australia) Pty Ltd and arrangements are in place to redirect any queries or complaints concerning the products to Bayer Australia Ltd.

 

 


Attachment

List of products to which the consent applies

AUST R

ARTG Label Name

91116

AERIUS desloratadine 5mg tablet

97260 

AERIUS FOR CHILDREN SYRUP desloratadine 2.5mg/5mL oral liquid

169329

CHILDREN'S CLARATYNE loratadine 5mg chewable tablet

208800

CHILDREN'S CLARATYNE loratadine 1mg/mL grape flavour oral liquid

44453

CHILDREN'S CLARATYNE loratadine 1mg/mL peach flavour oral liquid

34698

CLARATYNE loratadine  1Omg tablet

200430

CLARATYNE loratadine 10mg tablet (general sale)

175273

CLARATYNE LIQUID-CAPSULES loratadine 10mg capsule

207173

CLARATYNE LIQUID-CAPSULES  loratadine 10mg capsule (general sale)

217147

CLARATYNE REDITABS loratadine 10mg orally disintegrating tablet

53516

CLARATYNE-D WITH DECONGESTANT tablet

18815

DEMAZIN 6 HOUR RELIEF tablet

218997

DEMAZIN 12 HOUR RELIEF NASAL SPRAY oxymetazoline hydrochloride

136194

DEMAZIN CHESTY COUGH RELIEF SYRUP oral liquid

97036

DEMAZIN COLD & FLU tablet

 

97031

DEMAZIN COUGH, COLD & FLU tablet

18813

DEMAZIN COLD RELIEF BLUE SYRUP bottle

57378

DEMAZIN COLD RELIEF COLOUR FREE SYRUP bottle

151700

DEMAZIN COUGH & COLD RELIEF SYRUP bottle

133205

DEMAZIN DAY & NIGHT COLD & FLU tablet

152024

DEMAZIN PE COLD & FLU RELIEF tablet

152023

DEMAZIN PE COLD & FLU DAY & NIGHT tablet

161596

DRIXINE DECONGESTANT NASAL SPRAY oxymetazoline hydrochloride

181889

DRIXINE NO DRIP FORMULA MENTHOL AROMA PUMP MIST NASAL

SPRAY oxymetazoline hydrochloride 500mcg/mL

179875

DRIXINE NO DRIP FORMULA MOISTURISING PUMP MIST NASAL SPRAY

oxymetazoline hydrochloride 500mcg/mL

166852

DRIXINE NO DRIP FORMULA ORIGINAL PUMP MIST NASAL SPRAY

oxymetazoline hydrochloride 500mcg/mL

215798

NASONEX ALLERGY mometasone furoate 50 mcg/actuation nasal spray

 

18197

POLARAMINE SYRUP dexchlorphenirami ne maleate 0.4mg/mL

154653

POLARAMINE COLOUR-FREE dexchlorpheni ramine maleate 2mg tablet

18204

SOLARCAINE SPRAY benzocaine 10mg/g pressurised spray

18212

TINADERM tolnaftate 0.7mg/g pressurisq spray

18221

TINADERM POWDER tolnaftate 0.9mg/g pressurised spray

214265

VIVALAX bottle pack

214264

VIVALAX sachet pack

 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.